CIK 0001750284
- Non-accelerated filer
- Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 300409740
- Phone
- +1 415-651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at $29.38 ($154,274)
- 4 Open-market sale PRESIDENT AND CEO sold 3,044 shares at an average $30.01 ($91,353)
- 4 Open-market sale PRESIDENT AND CEO sold 871 shares at $30.05 ($26,174)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 12,000 shares at $24.97 ($299,640)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at an average $25.71 ($134,979)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 12,000 shares at an average $25.10 ($301,258)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at an average $26.51 ($139,191)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 12,000 shares at an average $24.80 ($297,626)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at an average $29.72 ($156,071)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Director acquired 99,556 shares (other)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 57,763 shares at an average $24.15 ($1,394,769)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 10 of 13 · 244 filings